A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202

被引：0
|
作者：
Syma Iqbal
Cathryn Rankin
Heinz-Josef Lenz
Philip J. Gold
Syed A. Ahmad
Anthony B. El-Khoueiry
Michael J. Messino
Randall F. Holcombe
Charles D. Blanke
机构：
[1] University of Southern California,Norris Comprehensive Cancer Center
[2] Southwest Oncology Group Statistical Center,Barrett Center, Department of Surgery
[3] Swedish Cancer Institute,undefined
[4] University of Cincinnati,undefined
[5] Southeast Cancer Control Consortium,undefined
[6] Inc. CCOP,undefined
[7] Cancer Care of WNC,undefined
[8] University of California at Irvine,undefined
[9] Chao Family CCC,undefined
[10] University of British Columbia,undefined
[11] and British Columbia Cancer Agency,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 68卷
关键词：
Gemcitabine; Capecitabine; Cholangiocarcinoma; Gallbladder; Clinical trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1595 / 1602
页数：7
相关论文
共 50 条
  • [1] A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202
    Iqbal, Syma
    Rankin, Cathryn
    Lenz, Heinz-Josef
    Gold, Philip J.
    Ahmad, Syed A.
    El-Khoueiry, Anthony B.
    Messino, Michael J.
    Holcombe, Randall F.
    Blanke, Charles D.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (06) : 1595 - 1602
  • [2] A Phase II Study of Gemcitabine and Capecitabine in Patients With Advanced Renal Cell Cancer Southwest Oncology Group Study S0312
    Van Veldhuizen, Peter J.
    Hussey, Michael
    Lara, Primo N., Jr.
    Mack, Philip C.
    Gandour-Edwards, Regina
    Clark, Joseph I.
    Lange, Marianne K.
    Crawford, David E.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (05): : 453 - 459
  • [3] SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma
    El-Khoueiry, Anthony B.
    Rankin, Cathryn J.
    Ben-Josef, Edgar
    Lenz, Heinz-Josef
    Gold, Philip J.
    Hamilton, R. Darryl
    Govindarajan, Rangaswamy
    Eng, Cathy
    Blanke, Charles D.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) : 1646 - 1651
  • [4] Phase II trial of gemcitabine plus irinotecan in patients with Esophageal cancer - A Southwest Oncology Group (SWOG) trial
    Williamson, SK
    McCoy, SA
    Gandara, DR
    Dakhil, SR
    Yost, KJ
    Paradelo, JC
    Atkins, JN
    Blanke, CD
    Abbruzzese, JL
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (02): : 116 - 122
  • [5] A phase II study of gemcitabine and capecitabine in metastatic renal cancer - A report of cancer and leukemia group B protocol 90008
    Stadler, Walter M.
    Halabi, Susan
    Rini, Brian
    Ernstoff, Marc S.
    Davila, Enrique
    Picus, Joel
    Barrier, Robert
    Small, Eric J.
    CANCER, 2006, 107 (06) : 1273 - 1279
  • [6] A phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma
    Cho, JY
    Nam, JS
    Park, MS
    Yu, JS
    Paik, YH
    Lee, SJ
    Lee, DK
    Yoon, DS
    YONSEI MEDICAL JOURNAL, 2005, 46 (04) : 526 - 531
  • [7] Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer
    Meyerhardt, Jeffrey A.
    Zhu, Andrew X.
    Stuart, Keith
    Ryan, David P.
    Blaszkowsky, Lawrence
    Lehman, Nicole
    Earle, Craig C.
    Kulke, Matthew H.
    Bhargava, Pankaj
    Fuchs, Charles S.
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (02) : 564 - 570
  • [8] SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma
    Anthony B. El-Khoueiry
    Cathryn J. Rankin
    Edgar Ben-Josef
    Heinz-Josef Lenz
    Philip J. Gold
    R. Darryl Hamilton
    Rangaswamy Govindarajan
    Cathy Eng
    Charles D. Blanke
    Investigational New Drugs, 2012, 30 : 1646 - 1651
  • [9] A Phase II Study of Gemcitabine and Capecitabine in Advanced Cholangiocarcinoma and Carcinoma of the Gallbladder: A Single-Institution Prospective Study
    Renuka V. Iyer
    John Gibbs
    Boris Kuvshinoff
    Marwan Fakih
    James Kepner
    Nancy Soehnlein
    David Lawrence
    Milind M. Javle
    Annals of Surgical Oncology, 2007, 14 : 3202 - 3209
  • [10] Phase-II Study of Gemcitabine and Cisplatin in Patients with Metastatic Biliary and Gallbladder Cancer
    Jeffrey A. Meyerhardt
    Andrew X. Zhu
    Keith Stuart
    David P. Ryan
    Lawrence Blaszkowsky
    Nicole Lehman
    Craig C. Earle
    Matthew H. Kulke
    Pankaj Bhargava
    Charles S. Fuchs
    Digestive Diseases and Sciences, 2008, 53 : 564 - 570
12345